Why should a CT urography be obtained before a cystoscopic transurethral resection of bladder tumor (TURBT)?

CT Urography Prior to Cystoscopy and TURBT

CT urography (CTU) should be obtained before cystoscopic TURBT to evaluate the entire urothelial tract for synchronous upper tract urothelial carcinoma (UTUC), which occurs in 2-4% of bladder cancer patients, and to provide anatomic characterization that aids in treatment planning. 1, 2

Primary Indications for Pre-TURBT CTU

Detection of Synchronous Upper Tract Disease

• Approximately 2-4% of patients with bladder cancer harbor concurrent UTUC, making comprehensive urothelial evaluation essential before proceeding with definitive bladder treatment 1
• CTU demonstrates 96% pooled sensitivity and 99% specificity for identifying urothelial carcinoma in the upper tracts, far superior to historical alternatives like intravenous urography 1
• Upper tract tumors present as high-grade invasive disease in approximately two-thirds of cases, with multifocal disease in 25-30% of UTUC patients 1

Anatomic Characterization and Treatment Planning

• CTU allows better anatomic characterization of bladder lesions and possible delineation of suspected depth of invasion before TURBT, as long as logistically feasible 2
• Cross-sectional imaging can visualize small masses that may be obscured on cystoscopy by contrast material or bowel gas, identify focal wall thickening, and distinguish enhancing tumors from nonenhancing calculi or blood clots 1
• CTU evaluates nonfunctioning or obstructed kidneys that would not excrete contrast medium required for other urographic techniques 1

Diagnostic Performance for Bladder Lesions

Accuracy and Limitations

• CTU demonstrates 91% diagnostic accuracy in detecting bladder urothelial carcinomas overall 1
• Sensitivity is 86.3% and specificity is 92.4% for bladder cancer detection, with positive predictive value of 63.6% and negative predictive value of 97.8% 3
• CTU may miss very small or flat lesions (particularly carcinoma in situ) that are more easily detected by direct cystoscopic visualization, which is why cystoscopy remains mandatory 1

Common Pitfalls

• False-positive results most commonly occur due to benign prostatic hyperplasia mimicking bladder lesions (12/43 false positives), followed by bladder trabeculation, post-treatment changes, and intravesical blood clots 3
• False-negative results are primarily technical: large postvoid residual with suboptimal bladder opacification or artifacts from bilateral hip arthroplasties obscuring the bladder 3
• Of 13 false negatives in one series, 11 were due to technique limitations where lesions were not visible retrospectively, while cystoscopy showed carcinoma in situ or urothelial erythema 1

Staging Capabilities

Local Staging

• CTU provides 87.8% accuracy in predicting TNM stage for upper tract disease 1
• Specific imaging features aid staging: spiculated tumor margins are associated with T2 or higher stages (87.5% sensitivity, 92.9% specificity for T3+ disease) 1
• High-grade hydronephrosis (grade 2-4) predicts non-organ-confined disease and pathological T3 or higher stage 1

Distant Metastases and Lymph Node Assessment

• CTU is the favored modality for detecting distant metastases and assessing retroperitoneal and pelvic lymph nodes in urothelial carcinoma 1
• Comprehensive abdomen-pelvis evaluation in a single examination provides efficient staging 1

Guideline Recommendations

Timing and Protocol

• The American College of Radiology (2024) and NCCN (2020) recommend CTU before TURBT when logistically feasible 1, 2
• CTU is generally the preferred approach to upper tract imaging in patients who can safely receive intravenous contrast agents 2
• The European Association of Urology indicates that CTU is generally the most accurate and preferred modality for diagnosis and staging of UTUC, both local and distant 1

Clinical Workflow

• If cystoscopy is performed first and identifies a bladder lesion, CTU is still essential to detect isolated or concurrent upper tract lesions before proceeding with definitive treatment 1
• In patients with positive urinary cytology and normal cystoscopy, the upper tracts and prostatic urethra must be evaluated, and ureteroscopy may be considered 2

Key Clinical Caveat

While CTU provides valuable staging information, it cannot replace TURBT and cystoscopy—the gold standard remains transurethral resection with adequate muscle sampling to assess invasion depth and guide treatment recommendations 2, 4, 5. CTU complements rather than substitutes for endoscopic evaluation, serving as the optimal method for comprehensive urothelial tract assessment before definitive surgical intervention.